Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

187 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Disease-modifying Therapies for Multiple Sclerosis.
Corboy JR, Goodin DS, Frohman EM. Corboy JR, et al. Among authors: goodin ds. Curr Treat Options Neurol. 2003 Jan;5(1):35-54. doi: 10.1007/s11940-003-0021-0. Curr Treat Options Neurol. 2003. PMID: 12521562
Neuromyelitis optica.
Cree BA, Goodin DS, Hauser SL. Cree BA, et al. Among authors: goodin ds. Semin Neurol. 2002 Jun;22(2):105-22. doi: 10.1055/s-2002-36534. Semin Neurol. 2002. PMID: 12524556 Review.
Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans.
Oksenberg JR, Barcellos LF, Cree BA, Baranzini SE, Bugawan TL, Khan O, Lincoln RR, Swerdlin A, Mignot E, Lin L, Goodin D, Erlich HA, Schmidt S, Thomson G, Reich DE, Pericak-Vance MA, Haines JL, Hauser SL. Oksenberg JR, et al. Am J Hum Genet. 2004 Jan;74(1):160-7. doi: 10.1086/380997. Epub 2003 Dec 10. Am J Hum Genet. 2004. PMID: 14669136 Free PMC article.
Marijuana and multiple sclerosis.
Goodin D. Goodin D. Lancet Neurol. 2004 Feb;3(2):79-80. doi: 10.1016/s1474-4422(03)00655-0. Lancet Neurol. 2004. PMID: 14746994 Review. No abstract available.
Enhanced benefit of increasing interferon beta-1a dose and frequency in relapsing multiple sclerosis: the EVIDENCE Study.
Schwid SR, Thorpe J, Sharief M, Sandberg-Wollheim M, Rammohan K, Wendt J, Panitch H, Goodin D, Li D, Chang P, Francis G; EVIDENCE (Evidence of Interferon Dose-Response: European North American Comparative Efficacy) Study Group; University of British Columbia MS/MRI Research Group. Schwid SR, et al. Arch Neurol. 2005 May;62(5):785-92. doi: 10.1001/archneur.62.5.785. Arch Neurol. 2005. PMID: 15883267 Clinical Trial.
187 results